期刊文献+

The ex vivo Microenviroments in MLTC of Poorly Immunogenic Tumor Cells Facilitate Polarization of CD4^+CD25^+ Regulatory T Cells 被引量:2

The ex vivo Microenviroments in MLTC of Poorly Immunogenic Tumor Cells Facilitate Polarization of CD4^+CD25^+ Regulatory T Cells
原文传递
导出
摘要 CD4^+CD25^+ regulatory T (TR) cells play an important role in maintaining a balanced peripheral immune system. Recent studies have shown that TR cells may also play a key role in suppressing anti-tumor immune response. In order to investigate the tumor immune microenvironment and its influence on TR polarization, poorly immunogenic tumor cell line Ds (C57BL/6, H-2^b), immunogenic tumor cell lines FBL3 (C57BL/6, H-2^b) and H22 BALB/c, H-2^d) were used to establish the syngeneic/allogeneic, poorly immunogenic/immunogenic mixed lymphocytes-tumor cell culture (MLTC). Our results revealed that the proportion of CD4^+CD25^+ T cells in MLTC of syngeneic primed splenocytes stimulated with D5 tumor cells was higher than that with H22 cells (0.43% vs 0.044%, and the similar results appeared in allogeneic splenocytes stimulated with D5 tumor cells (0.39% vs 0.04%). The splenocytes stimulated with supernatant from syngeneic MLTC of D5 tumor cells demonstrated higher proportion of CD4^+CD25^+ cells than that from allogeneic MLTC of D5 tumor cells, and the splenocytes stimulated with supernatant from syngeneic or allogeneic MLTC of H22 tumor cells generated lower proportion of CD4^+CD25^+ T cells than that of D5 tumor cells. The TGF-β1 and Th2-oriented cytokines (IL-4 and IL-10) were dominated in supernatants of syngeneic MLTC of poorly immunogenic tumor cells. Our results provided useful information for studying the mechanisms underlying tumor immune surveillance as well as for the tumor immunotherapy. CD4^+CD25^+ regulatory T (TR) cells play an important role in maintaining a balanced peripheral immune system. Recent studies have shown that TR cells may also play a key role in suppressing anti-tumor immune response. In order to investigate the tumor immune microenvironment and its influence on TR polarization, poorly immunogenic tumor cell line Ds (C57BL/6, H-2^b), immunogenic tumor cell lines FBL3 (C57BL/6, H-2^b) and H22 BALB/c, H-2^d) were used to establish the syngeneic/allogeneic, poorly immunogenic/immunogenic mixed lymphocytes-tumor cell culture (MLTC). Our results revealed that the proportion of CD4^+CD25^+ T cells in MLTC of syngeneic primed splenocytes stimulated with D5 tumor cells was higher than that with H22 cells (0.43% vs 0.044%, and the similar results appeared in allogeneic splenocytes stimulated with D5 tumor cells (0.39% vs 0.04%). The splenocytes stimulated with supernatant from syngeneic MLTC of D5 tumor cells demonstrated higher proportion of CD4^+CD25^+ cells than that from allogeneic MLTC of D5 tumor cells, and the splenocytes stimulated with supernatant from syngeneic or allogeneic MLTC of H22 tumor cells generated lower proportion of CD4^+CD25^+ T cells than that of D5 tumor cells. The TGF-β1 and Th2-oriented cytokines (IL-4 and IL-10) were dominated in supernatants of syngeneic MLTC of poorly immunogenic tumor cells. Our results provided useful information for studying the mechanisms underlying tumor immune surveillance as well as for the tumor immunotherapy.
出处 《Cellular & Molecular Immunology》 SCIE CAS CSCD 2006年第2期123-129,共7页 中国免疫学杂志(英文版)
关键词 immunogenic tumor immunoescape TR cell immunogenic tumor, immunoescape, TR cell
  • 相关文献

参考文献11

  • 1Rui Li,Dominik Rüttinger,Rong Li,Lü-Sheng Si,Yi-Li Wang.Analysis of the immunological microenvironment at the tumor site in patients with non-small cell lung cancer[J].Langenbeck’s Archives of Surgery.2003(6)
  • 2Wickelgren I.Immunology Policing the immune system[].Science.2004
  • 3Yu P,Lee Y,Liu W, et al.Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors[].The Journal of Experimental Medicine.2005
  • 4Sugiyama H.Cancer immunotherapy targeting Wilms‘ tumor gene WT1 product[].Expert Review of Vaccines.2005
  • 5Richard SB,Varuna A,Katie AW, et al.B cells and professional APCs recruit regulatory T cells via CCL4[].Nature Immunology.2001
  • 6Arens R,Schepers K,Nolte MA, et al.Tumor rejection induced by CD70-mediated quantitative and qualitative effects on effector CD8+ T cell formation[].The Journal of Experimental Medicine.2004
  • 7Curiel TJ,Coukos G,Zou L, et al.Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival[].Nature Medicine.2004
  • 8Fontenot JD,Gavin MA,Rudensky AY.Foxp3 programs the development and function of CD4+CD25+ regulatory T cells[].Nature Immunology.2003
  • 9Kast WM,Levitsky H,Marincola FM.Synopsis of the 6th Walker‘s cay colloquium on cancer vaccines and immunotherapy[].Journal of Translational Medicine.2004
  • 10Rosenberg SA,Yang JC,Restifo NP.Cancer immunotherapy: moving beyond current vaccines[].Nature Medicine.2004

同被引文献5

引证文献2

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部